Cingulate (CING) Short-Term Debt to Capital

Cingulate Inc. (CING) is a recognized biopharmaceutical player developing advanced methods for treating ADHD. The stock price history demonstrates the dynamics of an asset currently valued at 0.25. Experts value the brand for its progressive therapeutic developments, maintaining a positive image. The company's revenues rely on the sale of precision-release drugs through insurance funds and pharmacies.

cingulate.com (CING) Ratio of Short-Term Indebtedness to Capital: for the period 07/04/2022 - 10/28/2026

Metric breakdowns and analytics for Cingulate Corp (CING)

- price and consensus price forecast:

Stock Price Cingulate Inc.|CING - Fair Value Consensus

- market capitalization data:

Market Capitalization Cingulate Inc|CING - Enterprise Value

- book capitalization data:

Net Assets per Single Share Cingulate|CING - Accounting Value of Company|Market Value to Book Value Ratio cingulate.com|CING - Cumulative Company Assets

- debt and liquidity data:

General company analysis:CING - Cingulate

This indicator measures the proportion of liabilities maturing within one year relative to equity, allowing for an assessment of refinancing risks during a period of rising interest rates. By analyzing the current trend of short-term liabilities to equity, an investor can weigh the debt load against the high pricing power of Cingulate Inc. (CING), which is driven by the uniqueness of the CTRX platform and inelastic demand for ADHD therapy.

Competing companies

Alkermes Inc. (ALKS) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Avadel Corp (AVDL)|Short-Term Debt to Capital ATAI (Atai Life Sciences N.V.)|ghres.com - Short-Term Debt to Capital|Short-Term Debt to Equity MindMed (MNMD)|CMPS: Ratio of Short-Term Indebtedness to Capital|LBRX (LB Pharma) - Short-Term Debt to Equity|Bright Minds Corp (DRUG) - Short-Term Debt to Equity Ratio|VNDA (Vanda Pharmaceuticals) - Short-Term Debt to Capital|Short-Term Debt to Capital Cybin Corp (CYBN)|Alto Neuroscience (ANRO) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital NRXP (NRx Pharmaceuticals Inc.)|Silo Pharma (SILO) - Short-Term Debt to Equity|China Pharma Holdings Inc. - Current Liabilities to Equity|Short-Term Debt to Equity CMND (Clearmind Medicine Inc.)|pacificbayminerals.com (PBM) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio SPRC|Seelos Therapeutics Inc. (SEEL) - Current Liabilities to Capital|Short-Term Debt to Capital VRPX|Short-Term Debt to Equity Ratio Karuna Pharma